1984
DOI: 10.1097/00000441-198405000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione and Its Redox System in Diabetic Polymorphonuclear Leukocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
14
0

Year Published

1992
1992
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(16 citation statements)
references
References 12 publications
2
14
0
Order By: Relevance
“…A decrease in antioxidant capacity has been observed in the plasma of diabetic patients by several research groups [54,63,[75][76][77][78][79][80][81][82][83][84][85]. In a prospective study, Salonen et al found a decline of plasma RRR-a-tocopherol levels after the onset of type 2 diabetes [86].…”
Section: Which Markers Are Available?mentioning
confidence: 99%
“…A decrease in antioxidant capacity has been observed in the plasma of diabetic patients by several research groups [54,63,[75][76][77][78][79][80][81][82][83][84][85]. In a prospective study, Salonen et al found a decline of plasma RRR-a-tocopherol levels after the onset of type 2 diabetes [86].…”
Section: Which Markers Are Available?mentioning
confidence: 99%
“…Glutathione (GSH), an important intracellular antioxidant, is depleted in erythrocytes [1], plasma [2], leucocytes [3], and platelets from human diabetic patients [4] and in endothelial cells from diabetic rabbits [5]. The changes in GSH levels, which result in an oxidant/prooxidant imbalance, may predispose the cells to oxidantinduced damage and diabetic complications.…”
Section: Introductionmentioning
confidence: 99%
“…1 The increase in adverse cardiovascular outcome associated with hyperglycemia may result from impaired coronary microcirculatory responses to ischemia, 2 increased oxidative stress, 3,4 reduced bioavailability of nitric oxide, 5 and advanced glycation end product formation in the vessel wall and matrix. 6,7 Coronary collateral development is an important adaptive response to reducing myocardial ischemia. Impaired coronary collateral development contributes to the morbidity and mortality associated with CAD.…”
mentioning
confidence: 99%